Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 13/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 9/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.38 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.37 |
| ▸ | GRPR | P30550 | 3/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL259179 | 0.91 | SLC15A2 (0.38) | SLC15A2 | |
| SCHEMBL259178 | 0.91 | SLC15A2 (0.38) | SLC15A2 | |
| SCHEMBL29591786 | 0.91 | SLC15A2 (0.41) | OPRD1OPRM1OPRK1SLC15A2GRPR | |
| SCHEMBL29591894 | 0.89 | SLC15A2 (0.41) | OPRD1OPRM1OPRK1SLC15A2GRPR | |
| SCHEMBL29630538 | 0.87 | OPRD1 (0.38) | OPRD1OPRM1OPRK1SLC15A2 | |
| SCHEMBL30455342 | 0.86 | GRPR (0.37) | OPRD1OPRM1OPRK1SLC15A2GRPR | |
| SCHEMBL31323969 | 0.86 | SLC15A2 (0.34) | OPRD1OPRM1OPRK1SLC15A2GRPR | |
| SCHEMBL30666376 | 0.85 | OPRM1 (0.39) | OPRD1OPRM1OPRK1SLC15A2GRPR | |
| SCHEMBL30441904 | 0.85 | SLC15A2 (0.37) | OPRD1OPRM1OPRK1SLC15A2GRPR | |
| SCHEMBL29590377 | 0.85 | SLC15A2 (0.40) | SLC15A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |